These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 18097268)
1. Zoledronate-related osteonecrosis of the mandible. Ho L; Quan V; Henderson R Clin Nucl Med; 2008 Jan; 33(1):68-70. PubMed ID: 18097268 [TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates and phossy-jaw: breathing new life into an old problem. Ashcroft J Lancet Oncol; 2006 Jun; 7(6):447-9. PubMed ID: 16750492 [No Abstract] [Full Text] [Related]
13. Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case. Frei M; Bornstein MM; Schaller B; Reichart PA; Weimann R; Iizuka T J Oral Maxillofac Surg; 2010 Apr; 68(4):863-7. PubMed ID: 20307770 [No Abstract] [Full Text] [Related]
14. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: Report of 3 cases. Curi MM; Cossolin GS; Koga DH; Araújo SR; Feher O; dos Santos MO; Zardetto C J Oral Maxillofac Surg; 2007 Feb; 65(2):349-55. PubMed ID: 17236949 [No Abstract] [Full Text] [Related]
15. Bisphosphonate-associated osteonecrosis of the jaw: a six-year history of a case. Hewson ID N Z Dent J; 2011 Sep; 107(3):97-100. PubMed ID: 21957837 [TBL] [Abstract][Full Text] [Related]
16. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis. Ortega C; Montemurro F; Faggiuolo R; Vormola R; Nanni D; Goia F; Gilardino MO; Aglietta M Acta Oncol; 2007; 46(5):664-8. PubMed ID: 17562443 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma. Del Conte A; Bernardeschi P; La Ferla F; Turrisi G; D'Alessandro M; Montagnani F; Fiorentini G J Oral Maxillofac Surg; 2010 May; 68(5):1179-82. PubMed ID: 20185222 [No Abstract] [Full Text] [Related]
18. Osteonecrosis of the jaws due to bisphosphonate use. A review of 60 cases and treatment proposals. Magopoulos C; Karakinaris G; Telioudis Z; Vahtsevanos K; Dimitrakopoulos I; Antoniadis K; Delaroudis S Am J Otolaryngol; 2007; 28(3):158-63. PubMed ID: 17499130 [TBL] [Abstract][Full Text] [Related]
19. Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. Merigo E; Manfredi M; Meleti M; Corradi D; Vescovi P J Oral Pathol Med; 2005 Nov; 34(10):613-7. PubMed ID: 16202082 [TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate-related osteonecrosis of the mandible and maxilla: clinical and imaging features. Gill SB; Valencia MP; Sabino ML; Heideman GM; Michel MA J Comput Assist Tomogr; 2009; 33(3):449-54. PubMed ID: 19478642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]